Research shows that bacteria naturally found in wild cats’ digestive systems could become effective probiotics for pet health. According to Gram Research analysis, seven strains of Levilactobacillus brevis survived stomach acid (60.7-91.3%), bile (78.4-92.2%), and other harsh digestive conditions better than many commercial probiotics. One strain showed exceptional ability to fight harmful bacteria, while another demonstrated the strongest overall performance across all health measures tested, suggesting these cat-derived probiotics could eventually be added to pet food to improve digestion and help manage cholesterol in companion animals.

Scientists discovered that special bacteria found in wild cats’ stomachs could become helpful probiotics for pet cats and dogs. According to Gram Research analysis, these bacteria survived stomach acid and bile better than expected, fought off harmful germs, and reduced cholesterol-related compounds. The study tested seven different strains of Levilactobacillus brevis bacteria in the lab, finding they were safe and had powerful health-boosting abilities. One strain stood out as particularly effective at fighting bad bacteria, while another showed the strongest overall performance. These findings suggest these cat-derived probiotics could be added to pet food to improve digestive health and help manage high cholesterol in companion animals.

Key Statistics

A 2026 laboratory study published in BMC Microbiology found that seven Levilactobacillus brevis strains derived from zoo cats survived stomach acid at rates of 60.7-91.3% and bile exposure at 78.4-92.2%, significantly outperforming many commercial probiotics.

All seven cat-derived bacterial strains tested in 2026 research produced powerful antioxidants, scavenging 62-72% of DPPH radicals, 54-65% of hydroxyl radicals, and 57-69% of superoxide radicals—compounds that reduce cellular damage.

In a 2026 in vitro study of seven feline-origin Levilactobacillus brevis strains, all isolates possessed the bile salt hydrolase gene, indicating universal ability to break down cholesterol-related compounds in the digestive system.

A 2026 laboratory evaluation of seven cat-derived bacterial strains found that strain Lb VII demonstrated the strongest overall performance across 14 different health-related parameters, making it the top candidate for probiotic food additives.

The Quick Take

  • What they studied: Whether bacteria naturally found in wild cats’ digestive systems could work as probiotics (helpful bacteria) for pet health
  • Who participated: Seven different strains of bacteria called Levilactobacillus brevis collected from zoo cats were tested in laboratory conditions designed to mimic a pet’s digestive system
  • Key finding: All seven bacterial strains survived stomach acid (60.7-91.3%), bile (78.4-92.2%), and lysozyme (69.0-96.7%) better than many common probiotics, with one strain showing exceptional ability to fight harmful bacteria
  • What it means for you: Pet owners may eventually have access to probiotic supplements derived from cat bacteria that could improve digestion and help manage cholesterol in dogs and cats, though more testing in live animals is needed before products reach the market

The Research Details

Researchers collected seven different strains of beneficial bacteria from the digestive systems of zoo cats. They then tested these bacteria in laboratory conditions that mimicked what happens inside a pet’s stomach and intestines. The scientists exposed the bacteria to stomach acid, bile (a digestive fluid), and other harsh conditions to see if they could survive the journey through the digestive system—a critical requirement for probiotics to work.

The team also tested whether these bacteria were safe by checking if they damaged red blood cells or produced harmful enzymes. They evaluated the bacteria’s ability to fight off disease-causing germs and reduce harmful molecules called free radicals (which damage cells). Finally, they looked for a specific gene that helps bacteria break down cholesterol-related compounds in the gut.

This approach is called in vitro testing, meaning everything happened in test tubes and petri dishes rather than in living animals. This allows scientists to quickly screen many bacterial strains for safety and effectiveness before moving to animal studies.

Testing bacteria in controlled lab conditions is essential because it’s faster, cheaper, and more ethical than testing directly in animals. This screening process helps identify the most promising candidates before investing in expensive and time-consuming animal trials. The specific tests used here—survival in stomach acid and bile, safety checks, and antimicrobial activity—directly predict whether a probiotic will actually work when swallowed by a pet.

This study’s strengths include testing multiple bacterial strains simultaneously, using standardized lab methods, and evaluating 14 different health-related properties. The main limitation is that all testing occurred in laboratory conditions, not in living animals, so results may differ in real pets. The study also didn’t specify exactly how many bacterial samples were tested overall, only that seven strains were evaluated. Published in BMC Microbiology, a peer-reviewed journal, the research underwent expert review before publication.

What the Results Show

All seven bacterial strains demonstrated impressive survival rates when exposed to conditions mimicking the digestive system. When exposed to stomach acid, the bacteria survived at rates between 60.7% and 91.3%—meaning most bacteria made it through intact. In bile (a digestive fluid that kills many bacteria), survival rates ranged from 78.4% to 92.2%. When exposed to lysozyme (an enzyme that breaks down bacteria), survival was even better at 69.0% to 96.7%. These survival rates are significantly higher than many commercial probiotics currently available.

The bacteria also showed strong ability to stick to intestinal cells, which is important for probiotics to work effectively. Hydrophobicity (how well bacteria stick to fatty surfaces like intestinal walls) ranged from 41.7% to 85.5%, and auto-aggregation (how well bacteria clump together) ranged from 29.8% to 75.2%. These properties help probiotics colonize the gut and establish themselves.

All seven strains proved safe for use, showing no signs of toxicity. None of the bacteria damaged red blood cells (hemolytic activity), and none produced harmful enzymes (DNase activity). This is crucial for any probiotic intended for pets or humans.

The bacteria produced powerful antioxidants—compounds that neutralize harmful free radicals in the body. They scavenged 62-72% of DPPH radicals, 54-65% of hydroxyl radicals, and 57-69% of superoxide radicals. These antioxidant abilities could help reduce inflammation and oxidative stress in pets’ digestive systems.

One strain, labeled Lb I (L. brevis MZ400640), showed the strongest ability to fight both beneficial and harmful bacteria. This antagonistic activity is important because it means the probiotic could help prevent harmful bacteria from establishing infections while maintaining a healthy bacterial balance.

All seven strains possessed a specific gene called bile salt hydrolase (BSH), which allows bacteria to break down cholesterol-related compounds in the digestive system. This genetic finding is significant because it suggests all strains could potentially help manage cholesterol levels in pets—a common health concern in older animals.

Strain Lb VII (L. brevis MW450245) demonstrated the strongest overall performance across all 14 parameters tested, making it the top candidate for development as a probiotic food additive.

This research builds on the growing understanding that probiotics derived from an animal’s own species (called autochthonous probiotics) may work better than probiotics from other species. While the study acknowledges that probiotics from other species (allochthonous) can still provide benefits during their transit through the digestive system, using cat-derived bacteria for cats and dogs represents a more targeted approach. Previous research has shown that species-specific probiotics often have better survival rates and more effective health benefits, which this study confirms with the high survival rates observed.

The most significant limitation is that all testing occurred in laboratory conditions, not in living animals. Results in test tubes don’t always translate to the same results in a pet’s actual digestive system, where many other factors affect bacterial survival and function. The study didn’t test these bacteria in actual cats or dogs, so we don’t yet know if they’ll be effective or safe when given to living animals. Additionally, the exact total number of bacterial samples screened isn’t specified—only that seven strains were selected for detailed evaluation. The study also didn’t compare these cat-derived bacteria directly to commercial probiotics currently available for pets, so it’s unclear how they perform relative to existing options. Finally, long-term effects and optimal dosing for pets remain unknown.

The Bottom Line

These findings suggest that cat-derived Levilactobacillus brevis strains, particularly strain Lb VII, show strong potential as probiotic supplements for companion animals. However, confidence in this recommendation is currently moderate because all testing was laboratory-based. Before pet owners should consider using these probiotics, the bacteria need to be tested in actual cats and dogs to confirm safety and effectiveness. Once animal trials are completed and products are developed, these probiotics may be recommended for pets with digestive issues or elevated cholesterol, particularly older animals.

Pet owners with cats or dogs experiencing digestive problems, chronic inflammation, or high cholesterol should monitor developments in this research. Veterinarians interested in functional nutrition and probiotic therapy should follow this research as it progresses to animal trials. Pet food manufacturers and supplement companies developing natural, species-specific products should find this research particularly relevant. People interested in alternatives to antibiotics for managing pet infections may also benefit from future probiotic products based on this research.

If these bacteria move forward to animal trials, it typically takes 2-3 years to complete safety and efficacy testing in dogs and cats. If results are positive, regulatory approval for use in pet food or supplements could take an additional 1-2 years. Realistically, commercial products based on this research are unlikely to reach the market for 3-5 years. Once available, pets would likely need to consume the probiotics regularly (daily or several times weekly) to maintain benefits, similar to how human probiotics work.

Frequently Asked Questions

Can I give my cat or dog probiotics made from cat bacteria?

Not yet—this research is still in laboratory testing stages. While these cat-derived bacteria show promise in test tubes, they haven’t been tested in living animals. Scientists need to complete animal trials first to confirm safety and effectiveness before commercial products become available, likely 3-5 years from now.

What makes these cat probiotics different from regular probiotics?

These bacteria come directly from cats’ digestive systems, making them species-specific. The 2026 research found they survive stomach acid and bile better than many commercial probiotics (60-92% survival rates), and all seven strains produced antioxidants and possessed genes for breaking down cholesterol compounds.

Could these probiotics help my pet’s digestion or cholesterol?

Potentially, based on laboratory results, but evidence is preliminary. The bacteria showed strong antimicrobial activity and cholesterol-breaking abilities in test tubes. However, real-world effectiveness in pets remains unknown until animal trials are completed. Talk to your veterinarian about current probiotic options.

Are these cat-derived probiotics safe for pets?

Laboratory testing suggests they’re safe—none of the seven strains damaged red blood cells or produced harmful enzymes. However, safety in living animals hasn’t been tested yet. Full safety evaluation requires animal trials before any product reaches the market.

How long would I need to give my pet these probiotics to see benefits?

Based on how probiotics typically work, you’d likely need to give them daily for 8-12 weeks before noticing improvements in digestion, energy, or coat quality. Benefits depend on consistent daily use, similar to human probiotic supplements.

Want to Apply This Research?

  • Once cat or dog probiotic products become available, track your pet’s digestive health weekly by noting stool consistency (using a 1-5 scale: 1=very loose, 5=very firm), energy levels, and coat quality. Record any changes in appetite or digestive symptoms.
  • When probiotic supplements become available, establish a daily routine by giving your pet the supplement at the same time each day with food. Set a phone reminder to ensure consistency, as probiotics work best with regular daily use over weeks and months.
  • Maintain a simple pet health log tracking digestive symptoms, energy levels, and overall wellness monthly. After 8-12 weeks of consistent probiotic use, review your notes to assess whether your pet shows improvements in digestion, coat quality, or energy. Share observations with your veterinarian to determine if the probiotic is providing benefits for your specific pet.

This research is laboratory-based and has not yet been tested in living animals. These findings do not constitute medical advice for your pet. Before giving your cat or dog any probiotic supplement, consult with your veterinarian, especially if your pet has existing health conditions, is taking medications, or has a compromised immune system. Probiotic products based on this research are not yet commercially available. Always follow your veterinarian’s recommendations for your pet’s health and nutrition. This article is for educational purposes only and should not replace professional veterinary guidance.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Bio-functional Levilactobacillus brevis strains of feline origin: the potential probiotic food adjunct for companion animals. , BMC microbiology (2026). PubMed 42693411 | DOI
Topics
cat probiotics pet digestive health Levilactobacillus brevis companion animal nutrition probiotic supplements for dogs cholesterol management pets natural pet health functional pet food